GNH USA

Europe — EMA

Moxonidin Ingen Pharma (Moxonidine)

GNH USA supplies Moxonidin Ingen Pharma (Moxonidine), a imidazoline receptor agonist for essential hypertension. Request a quote for global supply.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidin Ingen Pharma, is an imidazoline receptor agonist presented as a tablet for oral use. It is used to treat essential hypertension in adult patients.

GNH USA supplies Moxonidin Ingen Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is an imidazoline receptor agonist indicated for the management of primary high‑blood‑pressure disorders.

Essential hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: reduced salivary flow causing discomfort. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: generalized tiredness or lack of energy.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate that may cause fainting. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hepatic dysfunction: abnormal liver enzyme elevations.

What precautions apply to Moxonidine?

Before initiating therapy, clinicians should consider several safety aspects. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Elderly patients: start at lower dose and titrate cautiously. - Concomitant antihypertensives: assess risk of additive blood‑pressure lowering effects. - Severe hypotension: contraindicated in patients with markedly low baseline pressure. - Store below 25°C: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with other medicines that affect blood pressure or sympathetic activity.

Major Interactions (Avoid): - Clonidine: combined use may cause profound hypotension. - Beta‑blockers: additive effect on heart rate and blood pressure. - Central acting antihypertensives (e.g., methyldopa): risk of excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive response. - ACE inhibitors or ARBs: monitor for additive hypotensive effect. - Lithium: possible increase in lithium levels; monitor serum concentrations.

Frequently asked questions

What is Moxonidin Ingen Pharma used for?+
Moxonidin Ingen Pharma contains the active ingredient moxonidine, which is prescribed to lower elevated blood pressure in adults with essential (primary) hypertension. By reducing sympathetic nervous system activity, it helps achieve target blood‑pressure levels and lowers cardiovascular risk.
How does moxonidine work?+
Moxonidine acts as a selective agonist at central imidazoline I1 receptors located in the brainstem. Activation of these receptors diminishes sympathetic outflow, leading to reduced norepinephrine release, lower peripheral vascular resistance, and a modest decrease in heart rate, all of which contribute to blood‑pressure reduction.
What is the usual dose of Moxonidin Ingen Pharma?+
The appropriate dose of Moxonidin Ingen Pharma is determined by the prescribing healthcare professional based on the individual’s blood‑pressure profile, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Moxonidin Ingen Pharma safe during pregnancy or breastfeeding?+
The safety of moxonidine in pregnancy and lactation has not been firmly established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Moxonidin Ingen Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does moxonidine compare with other antihypertensive classes?+
Moxonidine belongs to the imidazoline receptor agonist class, which lowers blood pressure primarily by reducing sympathetic tone. Unlike beta‑blockers or ACE inhibitors, it does not directly block adrenergic receptors or inhibit the renin‑angiotensin system, offering an alternative mechanism that may be useful when other agents are insufficient or poorly tolerated.
What are the storage and handling requirements for Moxonidin Ingen Pharma?+
Moxonidin Ingen Pharma tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.
How is Moxonidin Ingen Pharma administered?+
The medication is supplied as an oral tablet and is taken by mouth with or without food, as directed by the prescriber. Swallow the tablet whole; do not crush, chew, or split it unless specifically instructed by a healthcare professional.
What are the most serious risks associated with moxonidine?+
The most serious adverse events include severe hypotension, marked bradycardia, allergic reactions such as rash or anaphylaxis, and rare cases of liver enzyme elevation. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, difficulty breathing, or signs of liver dysfunction.
Who should not use Moxonidin Ingen Pharma?+
Moxonidin Ingen Pharma is contraindicated in patients with known severe hypotension, hypersensitivity to moxonidine or any tablet excipients, and in individuals for whom a rapid drop in blood pressure could be hazardous. Clinicians should also avoid use in patients with uncontrolled cardiac conduction disorders without careful monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Sia Ingen Pharma
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU